EM/ProfStella Valenzuela

Stella Valenzuela undertook her PhD studies in cell and molecular biology [identifying novel genes - CLIC1 and MIC-1 - from activated macrophage cells] at the Centre for Immunology (CFI), St Vincent's Hospital Sydney, obtaining her PhD from the University of NSW. Prior to this she had worked in the commercial sector, in the biotechnology companies Australian Monoclonal Development Pty Ltd and Cellabs Pty Ltd in research and development of monoclonal antibody technologies for research and diagnostic purposes. Following her PhD studies she was a Research Scientist at the CFI [functional studies of intracellular ion channel proteins - CLICs], later moving to the University of NSW to take up a position as an NHMRC Research Fellow [knockout mouse studies of S100 inflammatory proteins].

She later joined the University of Technology (UTS), Key Centre for Health Technologies [cellular responses to mobile phone frequencies]. She served as the Director for the ARC Research Hub for Integrated Device for End-User Analysis at Low Levels (IDEAL Hub) at UTS. Previously she has also served as both Head of School and Associate Head of School (Research) in the School of Life Sciences, UTS. 

Prof Valenzuela is a member of the Institute for Biomedical Materials and Devices and the Centre for Health Technologies and previously also a member of the Institute of Nanoscale Technologies, UTS. She has been instrumental in establishing Bionanotechnology research at UTS and has worked with her industry partner Surgical Diagnostics Pty Ltd, within the IDEAL HUB, an ARC Industry transformation hub, developing devices that use ion channel proteins and tethered membrane technologies and also partnered with Bod Science P/L developing proteins for use in cosmetic skin topical agents and for therapeutic purposes.